nodes	percent_of_prediction	percent_of_DWPC	metapath
Imipramine—CYP2E1—lung cancer	0.164	0.656	CbGaD
Imipramine—ABCB1—lung cancer	0.0858	0.344	CbGaD
Imipramine—ORM1—Gefitinib—lung cancer	0.0477	0.107	CbGbCtD
Imipramine—SLC22A3—Irinotecan—lung cancer	0.0356	0.0797	CbGbCtD
Imipramine—ORM1—Erlotinib—lung cancer	0.0282	0.0631	CbGbCtD
Imipramine—SLC22A2—Vinblastine—lung cancer	0.0187	0.0419	CbGbCtD
Imipramine—SLC22A2—Cisplatin—lung cancer	0.0172	0.0384	CbGbCtD
Imipramine—CYP2C19—Gefitinib—lung cancer	0.013	0.0291	CbGbCtD
Imipramine—CYP2C19—Teniposide—lung cancer	0.0126	0.0282	CbGbCtD
Imipramine—CYP3A7—Paclitaxel—lung cancer	0.0116	0.0261	CbGbCtD
Imipramine—CYP3A7-CYP3A51P—Paclitaxel—lung cancer	0.0116	0.0261	CbGbCtD
Imipramine—CYP3A7-CYP3A51P—Irinotecan—lung cancer	0.0115	0.0257	CbGbCtD
Imipramine—CYP3A7—Irinotecan—lung cancer	0.0115	0.0257	CbGbCtD
Imipramine—ABCB1—Topotecan—lung cancer	0.0115	0.0257	CbGbCtD
Imipramine—CYP2B6—Irinotecan—lung cancer	0.0109	0.0245	CbGbCtD
Imipramine—ABCB1—Gefitinib—lung cancer	0.0105	0.0235	CbGbCtD
Imipramine—CYP2D6—Gefitinib—lung cancer	0.0099	0.0221	CbGbCtD
Imipramine—CYP2B6—Cisplatin—lung cancer	0.00892	0.02	CbGbCtD
Imipramine—CYP2E1—Etoposide—lung cancer	0.00889	0.0199	CbGbCtD
Imipramine—CYP3A7—Docetaxel—lung cancer	0.00842	0.0188	CbGbCtD
Imipramine—CYP3A7-CYP3A51P—Docetaxel—lung cancer	0.00842	0.0188	CbGbCtD
Imipramine—ABCB1—Vinorelbine—lung cancer	0.00809	0.0181	CbGbCtD
Imipramine—CYP2D6—Vinorelbine—lung cancer	0.00763	0.0171	CbGbCtD
Imipramine—CYP1A2—Erlotinib—lung cancer	0.00711	0.0159	CbGbCtD
Imipramine—CYP3A4—Topotecan—lung cancer	0.00688	0.0154	CbGbCtD
Imipramine—ABCB1—Crizotinib—lung cancer	0.00644	0.0144	CbGbCtD
Imipramine—CYP3A4—Gefitinib—lung cancer	0.0063	0.0141	CbGbCtD
Imipramine—ABCB1—Gemcitabine—lung cancer	0.0063	0.0141	CbGbCtD
Imipramine—ABCB1—Erlotinib—lung cancer	0.00621	0.0139	CbGbCtD
Imipramine—CYP3A4—Teniposide—lung cancer	0.00611	0.0137	CbGbCtD
Imipramine—CYP2B6—Doxorubicin—lung cancer	0.00598	0.0134	CbGbCtD
Imipramine—CYP2D6—Erlotinib—lung cancer	0.00585	0.0131	CbGbCtD
Imipramine—ABCB1—Paclitaxel—lung cancer	0.00569	0.0127	CbGbCtD
Imipramine—ABCB1—Irinotecan—lung cancer	0.00561	0.0125	CbGbCtD
Imipramine—CYP1A2—Etoposide—lung cancer	0.00514	0.0115	CbGbCtD
Imipramine—HTR2A—phrenic nerve—lung cancer	0.00499	0.154	CbGeAlD
Imipramine—ABCB1—Vinblastine—lung cancer	0.00499	0.0112	CbGbCtD
Imipramine—CYP3A4—Vinorelbine—lung cancer	0.00485	0.0108	CbGbCtD
Imipramine—CYP2D6—Vinblastine—lung cancer	0.0047	0.0105	CbGbCtD
Imipramine—ABCB1—Cisplatin—lung cancer	0.00457	0.0102	CbGbCtD
Imipramine—ABCB1—Etoposide—lung cancer	0.00449	0.0101	CbGbCtD
Imipramine—ABCB1—Docetaxel—lung cancer	0.00411	0.0092	CbGbCtD
Imipramine—CYP3A4—Crizotinib—lung cancer	0.00386	0.00863	CbGbCtD
Imipramine—CYP3A4—Erlotinib—lung cancer	0.00372	0.00833	CbGbCtD
Imipramine—CYP3A4—Paclitaxel—lung cancer	0.00341	0.00762	CbGbCtD
Imipramine—CYP3A4—Irinotecan—lung cancer	0.00336	0.00752	CbGbCtD
Imipramine—ABCB1—Doxorubicin—lung cancer	0.00307	0.00686	CbGbCtD
Imipramine—CYP3A4—Vinblastine—lung cancer	0.00299	0.00669	CbGbCtD
Imipramine—ABCB1—Methotrexate—lung cancer	0.00297	0.00664	CbGbCtD
Imipramine—HTR7—pulmonary artery—lung cancer	0.00291	0.0898	CbGeAlD
Imipramine—CYP2D6—Doxorubicin—lung cancer	0.00289	0.00646	CbGbCtD
Imipramine—CYP3A4—Etoposide—lung cancer	0.00269	0.00602	CbGbCtD
Imipramine—CYP3A4—Docetaxel—lung cancer	0.00246	0.00551	CbGbCtD
Imipramine—CYP3A4—Doxorubicin—lung cancer	0.00184	0.00411	CbGbCtD
Imipramine—HTR2A—pulmonary artery—lung cancer	0.00181	0.056	CbGeAlD
Imipramine—KCND3—respiratory system—lung cancer	0.00123	0.0381	CbGeAlD
Imipramine—SLC22A4—mammary gland—lung cancer	0.000976	0.0302	CbGeAlD
Imipramine—CYP2C18—bronchus—lung cancer	0.000925	0.0286	CbGeAlD
Imipramine—KCND3—cardiac atrium—lung cancer	0.000857	0.0265	CbGeAlD
Imipramine—CHRM5—epithelium—lung cancer	0.000768	0.0237	CbGeAlD
Imipramine—ADRA1D—epithelium—lung cancer	0.000686	0.0212	CbGeAlD
Imipramine—KCND3—lung—lung cancer	0.000655	0.0202	CbGeAlD
Imipramine—SLC22A4—respiratory system—lung cancer	0.000651	0.0201	CbGeAlD
Imipramine—SLC6A3—respiratory system—lung cancer	0.000629	0.0194	CbGeAlD
Imipramine—SLC6A4—respiratory system—lung cancer	0.000576	0.0178	CbGeAlD
Imipramine—SLC22A4—bronchus—lung cancer	0.000535	0.0165	CbGeAlD
Imipramine—SLC6A2—respiratory system—lung cancer	0.000507	0.0157	CbGeAlD
Imipramine—HTR7—respiratory system—lung cancer	0.000489	0.0151	CbGeAlD
Imipramine—SLC22A4—trachea—lung cancer	0.000481	0.0149	CbGeAlD
Imipramine—DRD2—respiratory system—lung cancer	0.000462	0.0143	CbGeAlD
Imipramine—KCND3—lymph node—lung cancer	0.000448	0.0138	CbGeAlD
Imipramine—CHRM1—trachea—lung cancer	0.000424	0.0131	CbGeAlD
Imipramine—HTR7—epithelium—lung cancer	0.000409	0.0126	CbGeAlD
Imipramine—ORM1—bone marrow—lung cancer	0.000396	0.0122	CbGeAlD
Imipramine—ADRA1A—epithelium—lung cancer	0.000394	0.0122	CbGeAlD
Imipramine—CYP1A2—respiratory system—lung cancer	0.00039	0.012	CbGeAlD
Imipramine—SLC22A4—bone marrow—lung cancer	0.000381	0.0118	CbGeAlD
Imipramine—CYP2B6—respiratory system—lung cancer	0.000374	0.0115	CbGeAlD
Imipramine—HRH1—respiratory system—lung cancer	0.000365	0.0113	CbGeAlD
Imipramine—HTR7—trachea—lung cancer	0.000361	0.0112	CbGeAlD
Imipramine—ORM1—lung—lung cancer	0.000359	0.0111	CbGeAlD
Imipramine—CYP2E1—respiratory system—lung cancer	0.000351	0.0108	CbGeAlD
Imipramine—SLC22A4—lung—lung cancer	0.000345	0.0107	CbGeAlD
Imipramine—SLC6A3—lung—lung cancer	0.000334	0.0103	CbGeAlD
Imipramine—KCNH2—cardiac atrium—lung cancer	0.000316	0.00977	CbGeAlD
Imipramine—SLC22A3—lung—lung cancer	0.000314	0.00971	CbGeAlD
Imipramine—CYP2B6—bronchus—lung cancer	0.000308	0.00951	CbGeAlD
Imipramine—SLC6A4—lung—lung cancer	0.000306	0.00945	CbGeAlD
Imipramine—HRH1—epithelium—lung cancer	0.000305	0.00943	CbGeAlD
Imipramine—HTR2A—respiratory system—lung cancer	0.000305	0.00942	CbGeAlD
Imipramine—CHRM1—lung—lung cancer	0.000305	0.00942	CbGeAlD
Imipramine—HRH1—trachea—lung cancer	0.00027	0.00834	CbGeAlD
Imipramine—SLC6A2—lung—lung cancer	0.000269	0.00832	CbGeAlD
Imipramine—KCNH2—bone marrow—lung cancer	0.000267	0.00825	CbGeAlD
Imipramine—HTR7—lung—lung cancer	0.00026	0.00802	CbGeAlD
Imipramine—HTR2A—epithelium—lung cancer	0.000255	0.00787	CbGeAlD
Imipramine—ORM1—lymph node—lung cancer	0.000246	0.00759	CbGeAlD
Imipramine—DRD2—lung—lung cancer	0.000245	0.00758	CbGeAlD
Imipramine—SLC22A4—lymph node—lung cancer	0.000236	0.0073	CbGeAlD
Imipramine—HTR2A—trachea—lung cancer	0.000225	0.00696	CbGeAlD
Imipramine—SLC22A3—lymph node—lung cancer	0.000215	0.00664	CbGeAlD
Imipramine—CYP1A2—lung—lung cancer	0.000207	0.0064	CbGeAlD
Imipramine—ABCB1—respiratory system—lung cancer	0.0002	0.00617	CbGeAlD
Imipramine—CYP2B6—lung—lung cancer	0.000198	0.00613	CbGeAlD
Imipramine—HRH1—lung—lung cancer	0.000194	0.00599	CbGeAlD
Imipramine—Clomipramine—GSTP1—lung cancer	0.00019	0.102	CrCbGaD
Imipramine—CYP2E1—lung—lung cancer	0.000186	0.00576	CbGeAlD
Imipramine—SLC6A2—lymph node—lung cancer	0.000184	0.00569	CbGeAlD
Imipramine—ABCB1—epithelium—lung cancer	0.000167	0.00516	CbGeAlD
Imipramine—KCNH2—lymph node—lung cancer	0.000165	0.00511	CbGeAlD
Imipramine—HTR2A—lung—lung cancer	0.000162	0.005	CbGeAlD
Imipramine—ABCB1—trachea—lung cancer	0.000148	0.00456	CbGeAlD
Imipramine—HRH1—lymph node—lung cancer	0.000133	0.0041	CbGeAlD
Imipramine—ABCB1—bone marrow—lung cancer	0.000117	0.00362	CbGeAlD
Imipramine—Desipramine—CYP2A6—lung cancer	0.00011	0.0591	CrCbGaD
Imipramine—ABCB1—lung—lung cancer	0.000106	0.00328	CbGeAlD
Imipramine—Epinastine—ABCB1—lung cancer	9.65e-05	0.0517	CrCbGaD
Imipramine—Nortriptyline—CYP2E1—lung cancer	9.52e-05	0.0509	CrCbGaD
Imipramine—Oxcarbazepine—ALB—lung cancer	9.32e-05	0.0499	CrCbGaD
Imipramine—Body temperature increased—Irinotecan—lung cancer	9.1e-05	0.000601	CcSEcCtD
Imipramine—Decreased appetite—Cisplatin—lung cancer	9.09e-05	0.0006	CcSEcCtD
Imipramine—Hyperhidrosis—Paclitaxel—lung cancer	9.08e-05	0.000599	CcSEcCtD
Imipramine—Gastrointestinal disorder—Cisplatin—lung cancer	9.03e-05	0.000596	CcSEcCtD
Imipramine—Infestation—Methotrexate—lung cancer	9e-05	0.000594	CcSEcCtD
Imipramine—Infestation NOS—Methotrexate—lung cancer	9e-05	0.000594	CcSEcCtD
Imipramine—Drowsiness—Methotrexate—lung cancer	9e-05	0.000594	CcSEcCtD
Imipramine—Anorexia—Paclitaxel—lung cancer	8.95e-05	0.000591	CcSEcCtD
Imipramine—Vomiting—Vinorelbine—lung cancer	8.88e-05	0.000586	CcSEcCtD
Imipramine—Body temperature increased—Gemcitabine—lung cancer	8.87e-05	0.000585	CcSEcCtD
Imipramine—Rash—Vinorelbine—lung cancer	8.8e-05	0.000581	CcSEcCtD
Imipramine—Dermatitis—Vinorelbine—lung cancer	8.8e-05	0.000581	CcSEcCtD
Imipramine—Stomatitis—Methotrexate—lung cancer	8.77e-05	0.000579	CcSEcCtD
Imipramine—Methotrimeprazine—CYP2E1—lung cancer	8.76e-05	0.0469	CrCbGaD
Imipramine—Headache—Vinorelbine—lung cancer	8.75e-05	0.000578	CcSEcCtD
Imipramine—Syncope—Docetaxel—lung cancer	8.75e-05	0.000578	CcSEcCtD
Imipramine—Leukopenia—Docetaxel—lung cancer	8.73e-05	0.000576	CcSEcCtD
Imipramine—Eosinophilia—Doxorubicin—lung cancer	8.65e-05	0.000571	CcSEcCtD
Imipramine—Palpitations—Docetaxel—lung cancer	8.62e-05	0.000569	CcSEcCtD
Imipramine—Feeling abnormal—Cisplatin—lung cancer	8.62e-05	0.000569	CcSEcCtD
Imipramine—Paraesthesia—Etoposide—lung cancer	8.6e-05	0.000568	CcSEcCtD
Imipramine—Loss of consciousness—Docetaxel—lung cancer	8.57e-05	0.000566	CcSEcCtD
Imipramine—Somnolence—Etoposide—lung cancer	8.52e-05	0.000562	CcSEcCtD
Imipramine—Hepatobiliary disease—Methotrexate—lung cancer	8.51e-05	0.000562	CcSEcCtD
Imipramine—Insomnia—Paclitaxel—lung cancer	8.49e-05	0.000561	CcSEcCtD
Imipramine—Convulsion—Docetaxel—lung cancer	8.45e-05	0.000558	CcSEcCtD
Imipramine—Paraesthesia—Paclitaxel—lung cancer	8.43e-05	0.000557	CcSEcCtD
Imipramine—Hypertension—Docetaxel—lung cancer	8.42e-05	0.000556	CcSEcCtD
Imipramine—Agranulocytosis—Methotrexate—lung cancer	8.4e-05	0.000554	CcSEcCtD
Imipramine—Somnolence—Paclitaxel—lung cancer	8.35e-05	0.000551	CcSEcCtD
Imipramine—Decreased appetite—Etoposide—lung cancer	8.33e-05	0.00055	CcSEcCtD
Imipramine—Orphenadrine—CYP2E1—lung cancer	8.33e-05	0.0446	CrCbGaD
Imipramine—Maprotiline—ABCB1—lung cancer	8.31e-05	0.0445	CrCbGaD
Imipramine—Pancytopenia—Doxorubicin—lung cancer	8.3e-05	0.000548	CcSEcCtD
Imipramine—Nausea—Vinorelbine—lung cancer	8.29e-05	0.000548	CcSEcCtD
Imipramine—Gastrointestinal disorder—Etoposide—lung cancer	8.27e-05	0.000546	CcSEcCtD
Imipramine—Dyspepsia—Paclitaxel—lung cancer	8.27e-05	0.000546	CcSEcCtD
Imipramine—Body temperature increased—Cisplatin—lung cancer	8.27e-05	0.000546	CcSEcCtD
Imipramine—Asthenia—Irinotecan—lung cancer	8.26e-05	0.000545	CcSEcCtD
Imipramine—Fatigue—Etoposide—lung cancer	8.26e-05	0.000545	CcSEcCtD
Imipramine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—lung cancer	8.25e-05	0.000544	CcSEcCtD
Imipramine—Constipation—Etoposide—lung cancer	8.19e-05	0.000541	CcSEcCtD
Imipramine—Decreased appetite—Paclitaxel—lung cancer	8.16e-05	0.000539	CcSEcCtD
Imipramine—Dry mouth—Docetaxel—lung cancer	8.12e-05	0.000536	CcSEcCtD
Imipramine—Gastrointestinal disorder—Paclitaxel—lung cancer	8.11e-05	0.000535	CcSEcCtD
Imipramine—Fatigue—Paclitaxel—lung cancer	8.1e-05	0.000535	CcSEcCtD
Imipramine—Hepatitis—Methotrexate—lung cancer	8.08e-05	0.000533	CcSEcCtD
Imipramine—Pollakiuria—Doxorubicin—lung cancer	8.07e-05	0.000533	CcSEcCtD
Imipramine—Asthenia—Gemcitabine—lung cancer	8.05e-05	0.000531	CcSEcCtD
Imipramine—Constipation—Paclitaxel—lung cancer	8.03e-05	0.00053	CcSEcCtD
Imipramine—Confusional state—Docetaxel—lung cancer	8.03e-05	0.00053	CcSEcCtD
Imipramine—Urinary tract disorder—Methotrexate—lung cancer	7.98e-05	0.000527	CcSEcCtD
Imipramine—Photosensitivity reaction—Doxorubicin—lung cancer	7.97e-05	0.000526	CcSEcCtD
Imipramine—Anaphylactic shock—Docetaxel—lung cancer	7.96e-05	0.000526	CcSEcCtD
Imipramine—Oedema—Docetaxel—lung cancer	7.96e-05	0.000526	CcSEcCtD
Imipramine—Weight increased—Doxorubicin—lung cancer	7.95e-05	0.000525	CcSEcCtD
Imipramine—Pruritus—Gemcitabine—lung cancer	7.94e-05	0.000524	CcSEcCtD
Imipramine—Urethral disorder—Methotrexate—lung cancer	7.92e-05	0.000523	CcSEcCtD
Imipramine—Infection—Docetaxel—lung cancer	7.91e-05	0.000522	CcSEcCtD
Imipramine—Weight decreased—Doxorubicin—lung cancer	7.9e-05	0.000522	CcSEcCtD
Imipramine—Feeling abnormal—Etoposide—lung cancer	7.89e-05	0.000521	CcSEcCtD
Imipramine—Diarrhoea—Irinotecan—lung cancer	7.88e-05	0.00052	CcSEcCtD
Imipramine—Desipramine—CYP2E1—lung cancer	7.84e-05	0.0419	CrCbGaD
Imipramine—Gastrointestinal pain—Etoposide—lung cancer	7.83e-05	0.000517	CcSEcCtD
Imipramine—Shock—Docetaxel—lung cancer	7.83e-05	0.000517	CcSEcCtD
Imipramine—Nervous system disorder—Docetaxel—lung cancer	7.81e-05	0.000515	CcSEcCtD
Imipramine—Thrombocytopenia—Docetaxel—lung cancer	7.79e-05	0.000515	CcSEcCtD
Imipramine—Infestation—Doxorubicin—lung cancer	7.79e-05	0.000514	CcSEcCtD
Imipramine—Drowsiness—Doxorubicin—lung cancer	7.79e-05	0.000514	CcSEcCtD
Imipramine—Infestation NOS—Doxorubicin—lung cancer	7.79e-05	0.000514	CcSEcCtD
Imipramine—Tachycardia—Docetaxel—lung cancer	7.77e-05	0.000513	CcSEcCtD
Imipramine—Feeling abnormal—Paclitaxel—lung cancer	7.74e-05	0.000511	CcSEcCtD
Imipramine—Skin disorder—Docetaxel—lung cancer	7.73e-05	0.000511	CcSEcCtD
Imipramine—Gastrointestinal pain—Paclitaxel—lung cancer	7.68e-05	0.000507	CcSEcCtD
Imipramine—Diarrhoea—Gemcitabine—lung cancer	7.68e-05	0.000507	CcSEcCtD
Imipramine—Neuropathy peripheral—Doxorubicin—lung cancer	7.64e-05	0.000504	CcSEcCtD
Imipramine—Dizziness—Irinotecan—lung cancer	7.62e-05	0.000503	CcSEcCtD
Imipramine—Urticaria—Etoposide—lung cancer	7.61e-05	0.000502	CcSEcCtD
Imipramine—Stomatitis—Doxorubicin—lung cancer	7.59e-05	0.000501	CcSEcCtD
Imipramine—Jaundice—Doxorubicin—lung cancer	7.59e-05	0.000501	CcSEcCtD
Imipramine—Anorexia—Docetaxel—lung cancer	7.59e-05	0.000501	CcSEcCtD
Imipramine—Abdominal pain—Etoposide—lung cancer	7.57e-05	0.0005	CcSEcCtD
Imipramine—Body temperature increased—Etoposide—lung cancer	7.57e-05	0.0005	CcSEcCtD
Imipramine—Eye disorder—Methotrexate—lung cancer	7.55e-05	0.000498	CcSEcCtD
Imipramine—Tinnitus—Methotrexate—lung cancer	7.53e-05	0.000497	CcSEcCtD
Imipramine—Asthenia—Cisplatin—lung cancer	7.5e-05	0.000495	CcSEcCtD
Imipramine—Cardiac disorder—Methotrexate—lung cancer	7.5e-05	0.000495	CcSEcCtD
Imipramine—Urticaria—Paclitaxel—lung cancer	7.46e-05	0.000493	CcSEcCtD
Imipramine—Abdominal pain—Paclitaxel—lung cancer	7.42e-05	0.00049	CcSEcCtD
Imipramine—Body temperature increased—Paclitaxel—lung cancer	7.42e-05	0.00049	CcSEcCtD
Imipramine—Hepatobiliary disease—Doxorubicin—lung cancer	7.37e-05	0.000486	CcSEcCtD
Imipramine—Angiopathy—Methotrexate—lung cancer	7.33e-05	0.000484	CcSEcCtD
Imipramine—Vomiting—Irinotecan—lung cancer	7.32e-05	0.000483	CcSEcCtD
Imipramine—Immune system disorder—Methotrexate—lung cancer	7.29e-05	0.000482	CcSEcCtD
Imipramine—Mediastinal disorder—Methotrexate—lung cancer	7.28e-05	0.000481	CcSEcCtD
Imipramine—Agranulocytosis—Doxorubicin—lung cancer	7.27e-05	0.00048	CcSEcCtD
Imipramine—Triflupromazine—ABCB1—lung cancer	7.26e-05	0.0389	CrCbGaD
Imipramine—Rash—Irinotecan—lung cancer	7.26e-05	0.000479	CcSEcCtD
Imipramine—ABCB1—lymph node—lung cancer	7.26e-05	0.00224	CbGeAlD
Imipramine—Dermatitis—Irinotecan—lung cancer	7.25e-05	0.000479	CcSEcCtD
Imipramine—Headache—Irinotecan—lung cancer	7.21e-05	0.000476	CcSEcCtD
Imipramine—Insomnia—Docetaxel—lung cancer	7.2e-05	0.000475	CcSEcCtD
Imipramine—Diarrhoea—Cisplatin—lung cancer	7.15e-05	0.000472	CcSEcCtD
Imipramine—Paraesthesia—Docetaxel—lung cancer	7.15e-05	0.000472	CcSEcCtD
Imipramine—Alopecia—Methotrexate—lung cancer	7.14e-05	0.000471	CcSEcCtD
Imipramine—Vomiting—Gemcitabine—lung cancer	7.13e-05	0.000471	CcSEcCtD
Imipramine—Somnolence—Docetaxel—lung cancer	7.08e-05	0.000467	CcSEcCtD
Imipramine—Mental disorder—Methotrexate—lung cancer	7.08e-05	0.000467	CcSEcCtD
Imipramine—Rash—Gemcitabine—lung cancer	7.07e-05	0.000467	CcSEcCtD
Imipramine—Dermatitis—Gemcitabine—lung cancer	7.07e-05	0.000467	CcSEcCtD
Imipramine—Acepromazine—ALB—lung cancer	7.04e-05	0.0377	CrCbGaD
Imipramine—Malnutrition—Methotrexate—lung cancer	7.03e-05	0.000464	CcSEcCtD
Imipramine—Headache—Gemcitabine—lung cancer	7.03e-05	0.000464	CcSEcCtD
Imipramine—Dyspepsia—Docetaxel—lung cancer	7.01e-05	0.000463	CcSEcCtD
Imipramine—Hepatitis—Doxorubicin—lung cancer	6.99e-05	0.000462	CcSEcCtD
Imipramine—Hypoaesthesia—Doxorubicin—lung cancer	6.96e-05	0.000459	CcSEcCtD
Imipramine—Decreased appetite—Docetaxel—lung cancer	6.92e-05	0.000457	CcSEcCtD
Imipramine—Urinary tract disorder—Doxorubicin—lung cancer	6.91e-05	0.000456	CcSEcCtD
Imipramine—Dysgeusia—Methotrexate—lung cancer	6.88e-05	0.000455	CcSEcCtD
Imipramine—Thioproperazine—ALB—lung cancer	6.88e-05	0.0368	CrCbGaD
Imipramine—Gastrointestinal disorder—Docetaxel—lung cancer	6.87e-05	0.000454	CcSEcCtD
Imipramine—Asthenia—Etoposide—lung cancer	6.87e-05	0.000454	CcSEcCtD
Imipramine—Fatigue—Docetaxel—lung cancer	6.86e-05	0.000453	CcSEcCtD
Imipramine—Urethral disorder—Doxorubicin—lung cancer	6.85e-05	0.000453	CcSEcCtD
Imipramine—Nausea—Irinotecan—lung cancer	6.84e-05	0.000452	CcSEcCtD
Imipramine—Constipation—Docetaxel—lung cancer	6.81e-05	0.000449	CcSEcCtD
Imipramine—Pruritus—Etoposide—lung cancer	6.78e-05	0.000447	CcSEcCtD
Imipramine—Pipotiazine—ALB—lung cancer	6.77e-05	0.0362	CrCbGaD
Imipramine—Asthenia—Paclitaxel—lung cancer	6.74e-05	0.000445	CcSEcCtD
Imipramine—Chlorpromazine—CYP2E1—lung cancer	6.68e-05	0.0358	CrCbGaD
Imipramine—Nausea—Gemcitabine—lung cancer	6.66e-05	0.00044	CcSEcCtD
Imipramine—Vomiting—Cisplatin—lung cancer	6.65e-05	0.000439	CcSEcCtD
Imipramine—Pruritus—Paclitaxel—lung cancer	6.64e-05	0.000439	CcSEcCtD
Imipramine—Vision blurred—Methotrexate—lung cancer	6.63e-05	0.000437	CcSEcCtD
Imipramine—Amitriptyline—CYP2E1—lung cancer	6.61e-05	0.0354	CrCbGaD
Imipramine—Rash—Cisplatin—lung cancer	6.59e-05	0.000435	CcSEcCtD
Imipramine—Dermatitis—Cisplatin—lung cancer	6.59e-05	0.000435	CcSEcCtD
Imipramine—Feeling abnormal—Docetaxel—lung cancer	6.56e-05	0.000433	CcSEcCtD
Imipramine—Diarrhoea—Etoposide—lung cancer	6.55e-05	0.000433	CcSEcCtD
Imipramine—Eye disorder—Doxorubicin—lung cancer	6.54e-05	0.000431	CcSEcCtD
Imipramine—Ill-defined disorder—Methotrexate—lung cancer	6.52e-05	0.000431	CcSEcCtD
Imipramine—Tinnitus—Doxorubicin—lung cancer	6.52e-05	0.00043	CcSEcCtD
Imipramine—Gastrointestinal pain—Docetaxel—lung cancer	6.51e-05	0.00043	CcSEcCtD
Imipramine—Cardiac disorder—Doxorubicin—lung cancer	6.49e-05	0.000428	CcSEcCtD
Imipramine—Flushing—Doxorubicin—lung cancer	6.49e-05	0.000428	CcSEcCtD
Imipramine—Diarrhoea—Paclitaxel—lung cancer	6.43e-05	0.000424	CcSEcCtD
Imipramine—Angiopathy—Doxorubicin—lung cancer	6.34e-05	0.000419	CcSEcCtD
Imipramine—Malaise—Methotrexate—lung cancer	6.34e-05	0.000419	CcSEcCtD
Imipramine—Dizziness—Etoposide—lung cancer	6.33e-05	0.000418	CcSEcCtD
Imipramine—Immune system disorder—Doxorubicin—lung cancer	6.32e-05	0.000417	CcSEcCtD
Imipramine—Mediastinal disorder—Doxorubicin—lung cancer	6.3e-05	0.000416	CcSEcCtD
Imipramine—Abdominal pain—Docetaxel—lung cancer	6.29e-05	0.000415	CcSEcCtD
Imipramine—Body temperature increased—Docetaxel—lung cancer	6.29e-05	0.000415	CcSEcCtD
Imipramine—Leukopenia—Methotrexate—lung cancer	6.29e-05	0.000415	CcSEcCtD
Imipramine—Arrhythmia—Doxorubicin—lung cancer	6.25e-05	0.000412	CcSEcCtD
Imipramine—Dizziness—Paclitaxel—lung cancer	6.21e-05	0.00041	CcSEcCtD
Imipramine—Nausea—Cisplatin—lung cancer	6.21e-05	0.00041	CcSEcCtD
Imipramine—Alopecia—Doxorubicin—lung cancer	6.18e-05	0.000408	CcSEcCtD
Imipramine—Mental disorder—Doxorubicin—lung cancer	6.13e-05	0.000404	CcSEcCtD
Imipramine—Convulsion—Methotrexate—lung cancer	6.09e-05	0.000402	CcSEcCtD
Imipramine—Vomiting—Etoposide—lung cancer	6.09e-05	0.000402	CcSEcCtD
Imipramine—Malnutrition—Doxorubicin—lung cancer	6.09e-05	0.000402	CcSEcCtD
Imipramine—Carbamazepine—ABCB1—lung cancer	6.06e-05	0.0324	CrCbGaD
Imipramine—Rash—Etoposide—lung cancer	6.04e-05	0.000399	CcSEcCtD
Imipramine—Dermatitis—Etoposide—lung cancer	6.03e-05	0.000398	CcSEcCtD
Imipramine—Headache—Etoposide—lung cancer	6e-05	0.000396	CcSEcCtD
Imipramine—Tension—Doxorubicin—lung cancer	5.97e-05	0.000394	CcSEcCtD
Imipramine—Vomiting—Paclitaxel—lung cancer	5.97e-05	0.000394	CcSEcCtD
Imipramine—Dysgeusia—Doxorubicin—lung cancer	5.96e-05	0.000394	CcSEcCtD
Imipramine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lung cancer	5.94e-05	0.000392	CcSEcCtD
Imipramine—Rash—Paclitaxel—lung cancer	5.92e-05	0.000391	CcSEcCtD
Imipramine—Dermatitis—Paclitaxel—lung cancer	5.92e-05	0.000391	CcSEcCtD
Imipramine—Discomfort—Methotrexate—lung cancer	5.91e-05	0.00039	CcSEcCtD
Imipramine—Nervousness—Doxorubicin—lung cancer	5.91e-05	0.00039	CcSEcCtD
Imipramine—Headache—Paclitaxel—lung cancer	5.88e-05	0.000388	CcSEcCtD
Imipramine—Confusional state—Methotrexate—lung cancer	5.79e-05	0.000382	CcSEcCtD
Imipramine—Anaphylactic shock—Methotrexate—lung cancer	5.74e-05	0.000379	CcSEcCtD
Imipramine—Vision blurred—Doxorubicin—lung cancer	5.74e-05	0.000379	CcSEcCtD
Imipramine—Asthenia—Docetaxel—lung cancer	5.71e-05	0.000377	CcSEcCtD
Imipramine—Infection—Methotrexate—lung cancer	5.7e-05	0.000376	CcSEcCtD
Imipramine—Nausea—Etoposide—lung cancer	5.69e-05	0.000376	CcSEcCtD
Imipramine—Ill-defined disorder—Doxorubicin—lung cancer	5.65e-05	0.000373	CcSEcCtD
Imipramine—Pruritus—Docetaxel—lung cancer	5.63e-05	0.000372	CcSEcCtD
Imipramine—Nervous system disorder—Methotrexate—lung cancer	5.63e-05	0.000371	CcSEcCtD
Imipramine—Thrombocytopenia—Methotrexate—lung cancer	5.62e-05	0.000371	CcSEcCtD
Imipramine—Agitation—Doxorubicin—lung cancer	5.59e-05	0.000369	CcSEcCtD
Imipramine—Nausea—Paclitaxel—lung cancer	5.58e-05	0.000368	CcSEcCtD
Imipramine—Skin disorder—Methotrexate—lung cancer	5.57e-05	0.000368	CcSEcCtD
Imipramine—Hyperhidrosis—Methotrexate—lung cancer	5.55e-05	0.000366	CcSEcCtD
Imipramine—Malaise—Doxorubicin—lung cancer	5.49e-05	0.000362	CcSEcCtD
Imipramine—Anorexia—Methotrexate—lung cancer	5.47e-05	0.000361	CcSEcCtD
Imipramine—Syncope—Doxorubicin—lung cancer	5.46e-05	0.00036	CcSEcCtD
Imipramine—Leukopenia—Doxorubicin—lung cancer	5.45e-05	0.00036	CcSEcCtD
Imipramine—Diarrhoea—Docetaxel—lung cancer	5.45e-05	0.00036	CcSEcCtD
Imipramine—Palpitations—Doxorubicin—lung cancer	5.38e-05	0.000355	CcSEcCtD
Imipramine—Clomipramine—ALB—lung cancer	5.35e-05	0.0286	CrCbGaD
Imipramine—Loss of consciousness—Doxorubicin—lung cancer	5.35e-05	0.000353	CcSEcCtD
Imipramine—Convulsion—Doxorubicin—lung cancer	5.27e-05	0.000348	CcSEcCtD
Imipramine—Dizziness—Docetaxel—lung cancer	5.26e-05	0.000348	CcSEcCtD
Imipramine—Hypertension—Doxorubicin—lung cancer	5.26e-05	0.000347	CcSEcCtD
Imipramine—Nortriptyline—ALB—lung cancer	5.23e-05	0.028	CrCbGaD
Imipramine—Insomnia—Methotrexate—lung cancer	5.19e-05	0.000343	CcSEcCtD
Imipramine—Anxiety—Doxorubicin—lung cancer	5.16e-05	0.000341	CcSEcCtD
Imipramine—Paraesthesia—Methotrexate—lung cancer	5.15e-05	0.00034	CcSEcCtD
Imipramine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—lung cancer	5.15e-05	0.00034	CcSEcCtD
Imipramine—Discomfort—Doxorubicin—lung cancer	5.12e-05	0.000338	CcSEcCtD
Imipramine—Clomipramine—ABCB1—lung cancer	5.11e-05	0.0273	CrCbGaD
Imipramine—Somnolence—Methotrexate—lung cancer	5.1e-05	0.000337	CcSEcCtD
Imipramine—Dry mouth—Doxorubicin—lung cancer	5.07e-05	0.000335	CcSEcCtD
Imipramine—Vomiting—Docetaxel—lung cancer	5.06e-05	0.000334	CcSEcCtD
Imipramine—Dyspepsia—Methotrexate—lung cancer	5.05e-05	0.000333	CcSEcCtD
Imipramine—Rash—Docetaxel—lung cancer	5.02e-05	0.000331	CcSEcCtD
Imipramine—Dermatitis—Docetaxel—lung cancer	5.01e-05	0.000331	CcSEcCtD
Imipramine—Confusional state—Doxorubicin—lung cancer	5.01e-05	0.000331	CcSEcCtD
Imipramine—Decreased appetite—Methotrexate—lung cancer	4.99e-05	0.000329	CcSEcCtD
Imipramine—Headache—Docetaxel—lung cancer	4.99e-05	0.000329	CcSEcCtD
Imipramine—Anaphylactic shock—Doxorubicin—lung cancer	4.97e-05	0.000328	CcSEcCtD
Imipramine—Oedema—Doxorubicin—lung cancer	4.97e-05	0.000328	CcSEcCtD
Imipramine—Gastrointestinal disorder—Methotrexate—lung cancer	4.95e-05	0.000327	CcSEcCtD
Imipramine—Fatigue—Methotrexate—lung cancer	4.95e-05	0.000327	CcSEcCtD
Imipramine—Infection—Doxorubicin—lung cancer	4.94e-05	0.000326	CcSEcCtD
Imipramine—Shock—Doxorubicin—lung cancer	4.89e-05	0.000323	CcSEcCtD
Imipramine—Nervous system disorder—Doxorubicin—lung cancer	4.87e-05	0.000322	CcSEcCtD
Imipramine—Thrombocytopenia—Doxorubicin—lung cancer	4.86e-05	0.000321	CcSEcCtD
Imipramine—Tachycardia—Doxorubicin—lung cancer	4.85e-05	0.00032	CcSEcCtD
Imipramine—Skin disorder—Doxorubicin—lung cancer	4.83e-05	0.000319	CcSEcCtD
Imipramine—Hyperhidrosis—Doxorubicin—lung cancer	4.8e-05	0.000317	CcSEcCtD
Imipramine—Anorexia—Doxorubicin—lung cancer	4.74e-05	0.000313	CcSEcCtD
Imipramine—Nausea—Docetaxel—lung cancer	4.73e-05	0.000312	CcSEcCtD
Imipramine—Feeling abnormal—Methotrexate—lung cancer	4.73e-05	0.000312	CcSEcCtD
Imipramine—Trimipramine—ABCB1—lung cancer	4.7e-05	0.0251	CrCbGaD
Imipramine—Gastrointestinal pain—Methotrexate—lung cancer	4.69e-05	0.00031	CcSEcCtD
Imipramine—Urticaria—Methotrexate—lung cancer	4.56e-05	0.000301	CcSEcCtD
Imipramine—Body temperature increased—Methotrexate—lung cancer	4.54e-05	0.000299	CcSEcCtD
Imipramine—Abdominal pain—Methotrexate—lung cancer	4.54e-05	0.000299	CcSEcCtD
Imipramine—Promethazine—ABCB1—lung cancer	4.53e-05	0.0242	CrCbGaD
Imipramine—Insomnia—Doxorubicin—lung cancer	4.49e-05	0.000297	CcSEcCtD
Imipramine—Doxepin—ABCB1—lung cancer	4.48e-05	0.024	CrCbGaD
Imipramine—Paraesthesia—Doxorubicin—lung cancer	4.46e-05	0.000295	CcSEcCtD
Imipramine—Somnolence—Doxorubicin—lung cancer	4.42e-05	0.000292	CcSEcCtD
Imipramine—Dyspepsia—Doxorubicin—lung cancer	4.37e-05	0.000289	CcSEcCtD
Imipramine—Decreased appetite—Doxorubicin—lung cancer	4.32e-05	0.000285	CcSEcCtD
Imipramine—Gastrointestinal disorder—Doxorubicin—lung cancer	4.29e-05	0.000283	CcSEcCtD
Imipramine—Fatigue—Doxorubicin—lung cancer	4.28e-05	0.000283	CcSEcCtD
Imipramine—Constipation—Doxorubicin—lung cancer	4.25e-05	0.00028	CcSEcCtD
Imipramine—Asthenia—Methotrexate—lung cancer	4.12e-05	0.000272	CcSEcCtD
Imipramine—Desipramine—ABCB1—lung cancer	4.11e-05	0.022	CrCbGaD
Imipramine—Feeling abnormal—Doxorubicin—lung cancer	4.09e-05	0.00027	CcSEcCtD
Imipramine—Gastrointestinal pain—Doxorubicin—lung cancer	4.06e-05	0.000268	CcSEcCtD
Imipramine—Pruritus—Methotrexate—lung cancer	4.06e-05	0.000268	CcSEcCtD
Imipramine—Urticaria—Doxorubicin—lung cancer	3.95e-05	0.000261	CcSEcCtD
Imipramine—Abdominal pain—Doxorubicin—lung cancer	3.93e-05	0.000259	CcSEcCtD
Imipramine—Body temperature increased—Doxorubicin—lung cancer	3.93e-05	0.000259	CcSEcCtD
Imipramine—Diarrhoea—Methotrexate—lung cancer	3.93e-05	0.000259	CcSEcCtD
Imipramine—Dizziness—Methotrexate—lung cancer	3.79e-05	0.00025	CcSEcCtD
Imipramine—Chlorpromazine—ALB—lung cancer	3.67e-05	0.0196	CrCbGaD
Imipramine—Vomiting—Methotrexate—lung cancer	3.65e-05	0.000241	CcSEcCtD
Imipramine—Amitriptyline—ALB—lung cancer	3.63e-05	0.0194	CrCbGaD
Imipramine—Rash—Methotrexate—lung cancer	3.62e-05	0.000239	CcSEcCtD
Imipramine—Dermatitis—Methotrexate—lung cancer	3.61e-05	0.000239	CcSEcCtD
Imipramine—Headache—Methotrexate—lung cancer	3.59e-05	0.000237	CcSEcCtD
Imipramine—Asthenia—Doxorubicin—lung cancer	3.56e-05	0.000235	CcSEcCtD
Imipramine—Pruritus—Doxorubicin—lung cancer	3.52e-05	0.000232	CcSEcCtD
Imipramine—Chlorpromazine—ABCB1—lung cancer	3.5e-05	0.0187	CrCbGaD
Imipramine—Amitriptyline—ABCB1—lung cancer	3.46e-05	0.0185	CrCbGaD
Imipramine—Nausea—Methotrexate—lung cancer	3.41e-05	0.000225	CcSEcCtD
Imipramine—Diarrhoea—Doxorubicin—lung cancer	3.4e-05	0.000224	CcSEcCtD
Imipramine—Dizziness—Doxorubicin—lung cancer	3.29e-05	0.000217	CcSEcCtD
Imipramine—Vomiting—Doxorubicin—lung cancer	3.16e-05	0.000209	CcSEcCtD
Imipramine—Rash—Doxorubicin—lung cancer	3.13e-05	0.000207	CcSEcCtD
Imipramine—Dermatitis—Doxorubicin—lung cancer	3.13e-05	0.000207	CcSEcCtD
Imipramine—Headache—Doxorubicin—lung cancer	3.11e-05	0.000205	CcSEcCtD
Imipramine—Nausea—Doxorubicin—lung cancer	2.95e-05	0.000195	CcSEcCtD
Imipramine—ADRA1D—Signaling Pathways—KRAS—lung cancer	1.69e-06	1.44e-05	CbGpPWpGaD
Imipramine—HTR7—Signaling Pathways—HRAS—lung cancer	1.69e-06	1.43e-05	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—POMC—lung cancer	1.69e-06	1.43e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—CDKN1A—lung cancer	1.69e-06	1.43e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—CCND1—lung cancer	1.69e-06	1.43e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—PTEN—lung cancer	1.68e-06	1.43e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—JUN—lung cancer	1.68e-06	1.43e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—CCND1—lung cancer	1.68e-06	1.43e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—JUN—lung cancer	1.68e-06	1.42e-05	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism—ALB—lung cancer	1.67e-06	1.42e-05	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—TP53—lung cancer	1.67e-06	1.42e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—MMP9—lung cancer	1.67e-06	1.42e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—MMP9—lung cancer	1.66e-06	1.41e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—CDKN1A—lung cancer	1.66e-06	1.41e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—MMP9—lung cancer	1.66e-06	1.41e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—CDKN1A—lung cancer	1.66e-06	1.41e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—PTEN—lung cancer	1.66e-06	1.41e-05	CbGpPWpGaD
Imipramine—CYP2E1—Metabolism—PTEN—lung cancer	1.66e-06	1.41e-05	CbGpPWpGaD
Imipramine—ABCB1—Metabolism—PIK3CD—lung cancer	1.65e-06	1.41e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—CAT—lung cancer	1.65e-06	1.4e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—PTEN—lung cancer	1.65e-06	1.4e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—MMP9—lung cancer	1.65e-06	1.4e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—CDKN1A—lung cancer	1.65e-06	1.4e-05	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—PIK3CA—lung cancer	1.65e-06	1.4e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—VEGFA—lung cancer	1.65e-06	1.4e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—PTEN—lung cancer	1.65e-06	1.4e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—CDKN1A—lung cancer	1.65e-06	1.4e-05	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—APOA1—lung cancer	1.65e-06	1.4e-05	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—CREBBP—lung cancer	1.64e-06	1.4e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling by GPCR—AKT1—lung cancer	1.64e-06	1.4e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—PTEN—lung cancer	1.64e-06	1.4e-05	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—MAPK3—lung cancer	1.64e-06	1.39e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—MMP9—lung cancer	1.64e-06	1.39e-05	CbGpPWpGaD
Imipramine—ABCB1—Metabolism—ALB—lung cancer	1.63e-06	1.39e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—STAT3—lung cancer	1.63e-06	1.39e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—MMP9—lung cancer	1.63e-06	1.39e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—CDKN1A—lung cancer	1.63e-06	1.38e-05	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—MAPK3—lung cancer	1.63e-06	1.38e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—NRAS—lung cancer	1.63e-06	1.38e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—PTEN—lung cancer	1.63e-06	1.38e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—CDKN1A—lung cancer	1.63e-06	1.38e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—PTEN—lung cancer	1.62e-06	1.38e-05	CbGpPWpGaD
Imipramine—HTR6—Signaling Pathways—IL6—lung cancer	1.62e-06	1.37e-05	CbGpPWpGaD
Imipramine—HTR7—Signaling Pathways—IL6—lung cancer	1.62e-06	1.37e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling by GPCR—AKT1—lung cancer	1.62e-06	1.37e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling by GPCR—AKT1—lung cancer	1.61e-06	1.37e-05	CbGpPWpGaD
Imipramine—CYP3A7—Metabolism—PIK3CA—lung cancer	1.61e-06	1.37e-05	CbGpPWpGaD
Imipramine—CYP2B6—Metabolism—EP300—lung cancer	1.61e-06	1.37e-05	CbGpPWpGaD
Imipramine—SLC22A2—Metabolism—PIK3CA—lung cancer	1.61e-06	1.37e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—ABCB1—lung cancer	1.61e-06	1.37e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling by GPCR—AKT1—lung cancer	1.61e-06	1.37e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—EP300—lung cancer	1.61e-06	1.36e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling by GPCR—AKT1—lung cancer	1.6e-06	1.36e-05	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—TP53—lung cancer	1.6e-06	1.36e-05	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—HRAS—lung cancer	1.6e-06	1.35e-05	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—MYC—lung cancer	1.59e-06	1.35e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling by GPCR—AKT1—lung cancer	1.59e-06	1.35e-05	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—MYC—lung cancer	1.59e-06	1.35e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling by GPCR—AKT1—lung cancer	1.58e-06	1.34e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—TYMS—lung cancer	1.58e-06	1.34e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—EP300—lung cancer	1.58e-06	1.34e-05	CbGpPWpGaD
Imipramine—CYP2E1—Metabolism—EP300—lung cancer	1.58e-06	1.34e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—EP300—lung cancer	1.58e-06	1.34e-05	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	1.58e-06	1.34e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—EP300—lung cancer	1.57e-06	1.33e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—EP300—lung cancer	1.57e-06	1.33e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—GSTM1—lung cancer	1.56e-06	1.33e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—SRC—lung cancer	1.56e-06	1.33e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—MAPK3—lung cancer	1.56e-06	1.33e-05	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—PIK3CD—lung cancer	1.56e-06	1.32e-05	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—EGFR—lung cancer	1.56e-06	1.32e-05	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—PIK3CA—lung cancer	1.55e-06	1.32e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—EP300—lung cancer	1.55e-06	1.32e-05	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—EGFR—lung cancer	1.55e-06	1.32e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—EP300—lung cancer	1.55e-06	1.31e-05	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—ALB—lung cancer	1.54e-06	1.31e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—SRC—lung cancer	1.54e-06	1.3e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—SRC—lung cancer	1.53e-06	1.3e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—SRC—lung cancer	1.53e-06	1.3e-05	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—HRAS—lung cancer	1.53e-06	1.3e-05	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—IL6—lung cancer	1.53e-06	1.3e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—SRC—lung cancer	1.52e-06	1.29e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—VEGFA—lung cancer	1.52e-06	1.29e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—MYC—lung cancer	1.52e-06	1.29e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—SRC—lung cancer	1.51e-06	1.28e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—STAT3—lung cancer	1.51e-06	1.28e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—SRC—lung cancer	1.5e-06	1.28e-05	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—PIK3CG—lung cancer	1.5e-06	1.28e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—NRAS—lung cancer	1.5e-06	1.28e-05	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—TP53—lung cancer	1.5e-06	1.28e-05	CbGpPWpGaD
Imipramine—SLC22A1—Metabolism—PIK3CA—lung cancer	1.5e-06	1.27e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—VEGFA—lung cancer	1.5e-06	1.27e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—VEGFA—lung cancer	1.49e-06	1.27e-05	CbGpPWpGaD
Imipramine—HTR6—Signaling Pathways—AKT1—lung cancer	1.49e-06	1.27e-05	CbGpPWpGaD
Imipramine—HTR7—Signaling Pathways—AKT1—lung cancer	1.49e-06	1.27e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—VEGFA—lung cancer	1.49e-06	1.26e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—EGFR—lung cancer	1.48e-06	1.26e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—VEGFA—lung cancer	1.48e-06	1.26e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—STAT3—lung cancer	1.48e-06	1.26e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—CYP1A1—lung cancer	1.48e-06	1.26e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—STAT3—lung cancer	1.48e-06	1.26e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—NRAS—lung cancer	1.48e-06	1.26e-05	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism—PIK3CB—lung cancer	1.48e-06	1.26e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—NRAS—lung cancer	1.47e-06	1.25e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—STAT3—lung cancer	1.47e-06	1.25e-05	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—KRAS—lung cancer	1.47e-06	1.25e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—NRAS—lung cancer	1.47e-06	1.25e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—VEGFA—lung cancer	1.47e-06	1.25e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—STAT3—lung cancer	1.47e-06	1.25e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—ERCC2—lung cancer	1.47e-06	1.25e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—NRAS—lung cancer	1.47e-06	1.24e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—VEGFA—lung cancer	1.47e-06	1.24e-05	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—KRAS—lung cancer	1.46e-06	1.24e-05	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism—PTGS2—lung cancer	1.46e-06	1.24e-05	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—IL6—lung cancer	1.46e-06	1.24e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—STAT3—lung cancer	1.45e-06	1.24e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—NRAS—lung cancer	1.45e-06	1.23e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—STAT3—lung cancer	1.45e-06	1.23e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—NRAS—lung cancer	1.45e-06	1.23e-05	CbGpPWpGaD
Imipramine—ABCB1—Metabolism—PIK3CB—lung cancer	1.44e-06	1.23e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—MAPK3—lung cancer	1.44e-06	1.22e-05	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—HRAS—lung cancer	1.44e-06	1.22e-05	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—POMC—lung cancer	1.43e-06	1.22e-05	CbGpPWpGaD
Imipramine—ABCB1—Metabolism—PTGS2—lung cancer	1.43e-06	1.21e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—MAPK3—lung cancer	1.42e-06	1.2e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—MAPK3—lung cancer	1.41e-06	1.2e-05	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—AKT1—lung cancer	1.41e-06	1.2e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—MAPK3—lung cancer	1.41e-06	1.2e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—MAPK3—lung cancer	1.4e-06	1.19e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—KRAS—lung cancer	1.4e-06	1.19e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—MYC—lung cancer	1.4e-06	1.19e-05	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—CREBBP—lung cancer	1.39e-06	1.18e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—MAPK3—lung cancer	1.39e-06	1.18e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—MAPK3—lung cancer	1.39e-06	1.18e-05	CbGpPWpGaD
Imipramine—CHRM3—Metabolism—PIK3CA—lung cancer	1.39e-06	1.18e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—MYC—lung cancer	1.38e-06	1.17e-05	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—IL6—lung cancer	1.37e-06	1.17e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—MYC—lung cancer	1.37e-06	1.17e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—MYC—lung cancer	1.37e-06	1.16e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—EGFR—lung cancer	1.37e-06	1.16e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—MYC—lung cancer	1.37e-06	1.16e-05	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—PIK3CB—lung cancer	1.36e-06	1.15e-05	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—PIK3CA—lung cancer	1.35e-06	1.15e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—MYC—lung cancer	1.35e-06	1.15e-05	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—AKT1—lung cancer	1.35e-06	1.15e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—MYC—lung cancer	1.35e-06	1.15e-05	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—PTGS2—lung cancer	1.35e-06	1.14e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—EGFR—lung cancer	1.35e-06	1.14e-05	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—PIK3CA—lung cancer	1.35e-06	1.14e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—EGFR—lung cancer	1.34e-06	1.14e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—EGFR—lung cancer	1.34e-06	1.14e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—EGFR—lung cancer	1.34e-06	1.13e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—EGFR—lung cancer	1.32e-06	1.12e-05	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—PIK3CD—lung cancer	1.32e-06	1.12e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—EGFR—lung cancer	1.32e-06	1.12e-05	CbGpPWpGaD
Imipramine—CYP3A7—Metabolism—AKT1—lung cancer	1.32e-06	1.12e-05	CbGpPWpGaD
Imipramine—SLC22A2—Metabolism—AKT1—lung cancer	1.31e-06	1.12e-05	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—TP53—lung cancer	1.31e-06	1.11e-05	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—ALB—lung cancer	1.3e-06	1.11e-05	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—TP53—lung cancer	1.3e-06	1.11e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—KRAS—lung cancer	1.29e-06	1.1e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—PIK3CA—lung cancer	1.29e-06	1.09e-05	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism—PTEN—lung cancer	1.28e-06	1.08e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—KRAS—lung cancer	1.27e-06	1.08e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—APOA1—lung cancer	1.27e-06	1.08e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—KRAS—lung cancer	1.27e-06	1.08e-05	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—AKT1—lung cancer	1.27e-06	1.08e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—KRAS—lung cancer	1.27e-06	1.07e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—KRAS—lung cancer	1.26e-06	1.07e-05	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—HRAS—lung cancer	1.25e-06	1.06e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—KRAS—lung cancer	1.25e-06	1.06e-05	CbGpPWpGaD
Imipramine—ABCB1—Metabolism—PTEN—lung cancer	1.25e-06	1.06e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—TP53—lung cancer	1.25e-06	1.06e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—KRAS—lung cancer	1.25e-06	1.06e-05	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—HRAS—lung cancer	1.25e-06	1.06e-05	CbGpPWpGaD
Imipramine—SLC22A1—Metabolism—AKT1—lung cancer	1.23e-06	1.04e-05	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism—EP300—lung cancer	1.22e-06	1.03e-05	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—IL6—lung cancer	1.2e-06	1.02e-05	CbGpPWpGaD
Imipramine—CYP2B6—Metabolism—PIK3CA—lung cancer	1.19e-06	1.01e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—HRAS—lung cancer	1.19e-06	1.01e-05	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—IL6—lung cancer	1.19e-06	1.01e-05	CbGpPWpGaD
Imipramine—ABCB1—Metabolism—EP300—lung cancer	1.19e-06	1.01e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—PIK3CA—lung cancer	1.19e-06	1.01e-05	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—PTEN—lung cancer	1.17e-06	9.98e-06	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—PIK3CA—lung cancer	1.17e-06	9.93e-06	CbGpPWpGaD
Imipramine—CYP2E1—Metabolism—PIK3CA—lung cancer	1.17e-06	9.92e-06	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—PIK3CA—lung cancer	1.17e-06	9.91e-06	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—PIK3CA—lung cancer	1.16e-06	9.87e-06	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—PIK3CG—lung cancer	1.16e-06	9.85e-06	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—PIK3CA—lung cancer	1.16e-06	9.84e-06	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—PIK3CB—lung cancer	1.15e-06	9.78e-06	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—TP53—lung cancer	1.15e-06	9.76e-06	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—PIK3CA—lung cancer	1.15e-06	9.75e-06	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—PIK3CA—lung cancer	1.14e-06	9.72e-06	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—PTGS2—lung cancer	1.14e-06	9.69e-06	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—IL6—lung cancer	1.14e-06	9.69e-06	CbGpPWpGaD
Imipramine—CHRM3—Metabolism—AKT1—lung cancer	1.13e-06	9.62e-06	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—TP53—lung cancer	1.13e-06	9.6e-06	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—TP53—lung cancer	1.13e-06	9.58e-06	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—TP53—lung cancer	1.12e-06	9.55e-06	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—TP53—lung cancer	1.12e-06	9.52e-06	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—EP300—lung cancer	1.12e-06	9.51e-06	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—TP53—lung cancer	1.11e-06	9.43e-06	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—TP53—lung cancer	1.11e-06	9.4e-06	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—AKT1—lung cancer	1.11e-06	9.39e-06	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—POMC—lung cancer	1.1e-06	9.38e-06	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—AKT1—lung cancer	1.1e-06	9.34e-06	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—HRAS—lung cancer	1.1e-06	9.33e-06	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—HRAS—lung cancer	1.08e-06	9.18e-06	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—HRAS—lung cancer	1.08e-06	9.16e-06	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—HRAS—lung cancer	1.08e-06	9.14e-06	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—CREBBP—lung cancer	1.08e-06	9.13e-06	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—HRAS—lung cancer	1.07e-06	9.11e-06	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—HRAS—lung cancer	1.06e-06	9.02e-06	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—HRAS—lung cancer	1.06e-06	8.99e-06	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—AKT1—lung cancer	1.05e-06	8.94e-06	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—IL6—lung cancer	1.05e-06	8.93e-06	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—IL6—lung cancer	1.03e-06	8.79e-06	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—IL6—lung cancer	1.03e-06	8.77e-06	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—IL6—lung cancer	1.03e-06	8.74e-06	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—IL6—lung cancer	1.03e-06	8.72e-06	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—PIK3CD—lung cancer	1.02e-06	8.66e-06	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—IL6—lung cancer	1.02e-06	8.63e-06	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—IL6—lung cancer	1.01e-06	8.61e-06	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—ALB—lung cancer	1.01e-06	8.55e-06	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—PTEN—lung cancer	9.95e-07	8.45e-06	CbGpPWpGaD
Imipramine—CYP2B6—Metabolism—AKT1—lung cancer	9.74e-07	8.27e-06	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—AKT1—lung cancer	9.7e-07	8.24e-06	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—AKT1—lung cancer	9.55e-07	8.11e-06	CbGpPWpGaD
Imipramine—CYP2E1—Metabolism—AKT1—lung cancer	9.54e-07	8.1e-06	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—AKT1—lung cancer	9.53e-07	8.09e-06	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—AKT1—lung cancer	9.5e-07	8.07e-06	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—EP300—lung cancer	9.49e-07	8.06e-06	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—AKT1—lung cancer	9.47e-07	8.04e-06	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—AKT1—lung cancer	9.37e-07	7.96e-06	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—AKT1—lung cancer	9.35e-07	7.94e-06	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism—PIK3CA—lung cancer	9.01e-07	7.65e-06	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—PIK3CB—lung cancer	8.89e-07	7.55e-06	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—PTGS2—lung cancer	8.81e-07	7.48e-06	CbGpPWpGaD
Imipramine—ABCB1—Metabolism—PIK3CA—lung cancer	8.79e-07	7.47e-06	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—PIK3CA—lung cancer	8.29e-07	7.04e-06	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—PTEN—lung cancer	7.68e-07	6.52e-06	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism—AKT1—lung cancer	7.36e-07	6.25e-06	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—EP300—lung cancer	7.32e-07	6.22e-06	CbGpPWpGaD
Imipramine—ABCB1—Metabolism—AKT1—lung cancer	7.18e-07	6.1e-06	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—PIK3CA—lung cancer	7.02e-07	5.96e-06	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—AKT1—lung cancer	6.77e-07	5.75e-06	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—AKT1—lung cancer	5.73e-07	4.87e-06	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—PIK3CA—lung cancer	5.42e-07	4.6e-06	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—AKT1—lung cancer	4.43e-07	3.76e-06	CbGpPWpGaD
